Strober, B., Y. Tada, U. Mrowietz, M. Lebwohl, P. Foley, R. G. Langley, J. Barker, M. Wang, V. Vanvoorden, B. Szilagyi, V. Ciaravino, and C. Paul. “Bimekizumab Maintenance of Response through Three Years in Patients With Moderate to Severe Plaque Psoriasis Who Responded at Week 16: Results from the BE BRIGHT Open-Label Extension Trial”. SKIN The Journal of Cutaneous Medicine, vol. 6, no. 6, Nov. 2022, p. s65, doi:10.25251/skin.6.supp.65.